VOSEVI

sofosbuvir/velpatasvir/voxilaprevir · Gilead Sciences, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for VOSEVI, covering 2017-07-18 to 2023-09-27. Get the full timeline:

Most recent: EMA Authorised: Vosevi (sofosbuvir;velpatasvir;voxilaprevi) — Gilead Sciences Ireland UC